Global Expansion Focus Co-Diagnostics is actively participating in international health exhibitions and summits, such as the Riyadh Global Health Exhibition 2025 and the Maxim Growth Summit, indicating a strategic focus on expanding its global footprint and establishing partnerships in international markets, which presents opportunities for international sales channels and collaborations.

Innovative Diagnostic Platforms The company's development of the Co-Dx PCR Pro™ platform and its patented Co-Primers™ technology demonstrates a commitment to providing high-quality, affordable, point-of-care, and at-home diagnostic solutions, creating sales opportunities in remote, underserved, and home-testing markets.

Funding and Growth Potential Recent $7 million funding rounds suggest ongoing investor confidence in Co-Diagnostics’ technology and market potential, signaling readiness for expansion, increased marketing efforts, and sales initiatives targeting both existing and new customer segments in molecular diagnostics.

Target Market Opportunities With a mission to democratize molecular diagnostics particularly in regions with significant healthcare needs, there is a strong sales opportunity in underserved markets such as remote areas and developing countries, where affordable, high-quality PCR testing could significantly improve disease detection and management.

Industry Partnerships and Networking Active participation in industry events, investor conferences, and international expos provides avenues for strategic alliances, distribution partnerships, and key customer acquisition, especially among government health agencies, healthcare providers, and global health organizations.